Skip to main content
Premium Trial:

Request an Annual Quote

Golden Helix to Provide Free Software Under New Initiative

Premium

NEW YORK (GenomeWeb) – Golden Helix said this week that it is launching a new initiative called Golden Helix Gives Back through which it will provide its software for free to academic researchers with limited funds.

The company is accepting applications from academic researchers using DNA-Seq, RNA-Seq, GWAS, or CNV methodologies, who are interested in getting an annual license to the company's SNP & Variation Suite (SVS) or its VarSeq product free of charge. SVS is an integrated collection of tools for managing, analyzing, and visualizing multifaceted genomic and phenotypic data. VarSeq software streamlines the process of annotating and filtering variants obtained from next generation sequencing pipelines.

Applications will be evaluated based on the importance of the biological question under study and the impact it may have on the field; the overall study design and analysis methodology; the research application and its benefits; financial need; and how Golden Helix software will assist in the research effort.

The initiative will open on November 10 and applicants have until December 5 this year to turn in their proposals. Golden Helix will award the top 3 applicants with annual licenses to either one of its two products. The winners will be announced on December 18.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.